Pliant Therapeutics Inc

Open

1.16 4.5

Overview

Share price change

24h

Current

Min

1.12

Max

1.17

Key metrics

By Trading Economics

Income

3.5M

-20M

EPS

-0.32

Employees

49

EBITDA

8.6M

-20M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+140.54% upside

Dividends

By Acuity

Next Earnings

5 sie 2026

Market Stats

By TradingEconomics

Market Cap

-3.1M

71M

Previous open

-3.34

Previous close

1.16

Pliant Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

2 lip 2026, 23:56 UTC

Macro News

FTSE 100 Index rises in after-market hours as inflation concerns ease. Positive corporate news and U.S. employment data support the upward momentum.

2 lip 2026, 23:56 UTC

Correlated Moves

EUR/TRY is higher in Thursday's session, supported by a modest increase since Wednesday's close. The pair remains volatile within its one-month range.

2 lip 2026, 23:56 UTC

ETF Constituents

The Vanguard FTSE Emerging Markets ETF was little changed in after-market hours, with INFY, TCOM, and JD contributing slight declines.

2 lip 2026, 23:51 UTC

Asia equity markets decline amid semiconductor sell-off, while U.S. indices rise on weak job data easing rate hike fears; European markets gain as defensive sectors lead.

2 lip 2026, 23:51 UTC

U.S. job growth disappoints with only 57k added in June, prompting reassessment of Fed rate hike expectations, while global markets show mixed signals amid easing inflation concerns.

2 lip 2026, 23:51 UTC

US equity indices rise as lower-than-expected job growth eases interest rate hike fears, while European markets gain and Asian stocks face losses.

2 lip 2026, 23:51 UTC

European equity markets rise on positive economic data and easing inflation, with Germany's DAX up 1.9% and Italy's unemployment hitting a record low of 5.0%.

2 lip 2026, 23:51 UTC

Mexico's Inflation Rate Release on July 9, 2026: Market Eyes Rising Trends Amid Tariff and Oil Price Concerns.

2 lip 2026, 23:51 UTC

Mexican Inflation Rate Expected to Decline Further Ahead of July 9 Release, Influencing Market Sentiment Amid Global Trends.

2 lip 2026, 23:51 UTC

Social Media

Fox Corp shares are lower in after-market hours despite record viewership for the U.S. Men's National Team match, averaging 24.43 million viewers.

2 lip 2026, 23:51 UTC

Fiserv Inc. shares are higher in after-market trading, reflecting positive sentiment following weaker-than-expected job growth data that has eased rate hike concerns.

2 lip 2026, 23:51 UTC

Macro News
Social Media
ETF Constituents
Correlated Moves

The KOSPI index fell sharply, impacting the iShares MSCI South Korea ETF, which remained near unchanged in after-hours trading.

2 lip 2026, 23:51 UTC

Lam Research Corp shares are higher in after-market trading, reflecting positive sentiment following a weaker-than-expected jobs report and tempered rate hike fears.

2 lip 2026, 23:51 UTC

Terra is trading higher today, continuing its upward momentum since Wednesday's close. The asset remains below its 20-day moving average.

2 lip 2026, 23:51 UTC

PepsiCo Inc shares are lower in after-market hours, with no specific news identified to explain the decline amid generally positive broader market sentiment.

2 lip 2026, 23:46 UTC

Correlated Moves

J B Hunt Transport Services Inc shares are higher in after-market trading, following a modest increase since Thursday's close amid stable market conditions.

2 lip 2026, 23:46 UTC

The iShares Core U.S. Aggregate Bond ETF is trading lower in after-market hours, reflecting a decline since Thursday's close and nearing its one-month low.

2 lip 2026, 23:46 UTC

Macro News
ETF Constituents
Correlated Moves

Energy Select Sector SPDR Fund declines after-market, influenced by weak U.S. employment data and slight losses among major holdings like Exxon Mobil and Chevron.

2 lip 2026, 23:42 UTC

U.S. Trade Deficit Expected to Widen to $78.8 Billion in May 2026 Amid Economic Uncertainties and Geopolitical Tensions

2 lip 2026, 23:42 UTC

U.S. Exports Data Release on July 7 Expected to Reflect Mixed Performance Amid Global Economic Challenges and Tariff Changes

2 lip 2026, 23:42 UTC

U.S. Imports Data Release on July 7, 2026, Expected to Reflect Strong Growth Amid Tariff Changes and Supply Chain Adjustments

2 lip 2026, 23:42 UTC

Canada's Trade Surplus Expected to Continue Amid Geopolitical Tensions Ahead of July 7 Data Release

2 lip 2026, 23:41 UTC

Correlated Moves

NXP Semiconductors NV shares are higher in after-market trading, reflecting a modest increase since Thursday's close amid gains in Skyworks Solutions Inc.

2 lip 2026, 23:41 UTC

NetApp Inc shares are lower in after-market trading, with no specific news identified to explain the decline. The stock remains near its one-month trading range.

2 lip 2026, 23:41 UTC

News
Social Media

Meta shares rise in after-market trading as CEO Zuckerberg highlights upcoming AI benefits and announces new application Pocket, despite some setbacks.

2 lip 2026, 23:41 UTC

Macro News
Correlated Moves

Bitcoin reached a one-week high today, boosted by weaker U.S. employment data and optimism about Federal Reserve rate hikes. Related stocks also gained.

2 lip 2026, 23:36 UTC

The US Dollar Index is trading roughly flat amid routine price action. European equity markets closed positively, driven by gains in defensive sectors and pharmaceuticals.

2 lip 2026, 23:36 UTC

Correlated Moves
Macro News
ETF Constituents

The SPDR S&P Bank ETF is higher after hours, supported by Third Coast Bancshares' $30 million share repurchase program and mixed market performance.

2 lip 2026, 23:36 UTC

Kraft Heinz Co shares are lower in after-market hours, with no specific news identified to explain the movement. The stock briefly reached a session high earlier.

2 lip 2026, 23:32 UTC

News
Social Media

Microsoft launches AI initiative Microsoft Frontier Company with $2.5 billion backing. Shares are higher in after-market trading, continuing the broader software sector's upward trend.

Peer Comparison

Price change

Pliant Therapeutics Inc Forecast

Price Target

By TipRanks

140.54% upside

12 Months Forecast

Average 2.67 USD  140.54%

High 3 USD

Low 2 USD

Based on 5 Wall Street analysts offering 12 month price targets forPliant Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

5 ratings

1

Buy

4

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Pliant Therapeutics Inc

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. The company's lead candidate is bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which is in phase 2b trials for idiopathic pulmonary fibrosis and in phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325 for treatment of muscular dystrophies. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.
help-icon Live chat